Cancer-related direct-to-consumer advertising: A critical review

Nature Reviews Cancer

Volumn 11, Issue 2, 2011, Pages 142-150

  Kontos, Emily Z ^a   Viswanath, K ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCESS TO INFORMATION; ADVERTIZING; AWARENESS; CONSUMER HEALTH INFORMATION; DIRECT TO CONSUMER ADVERTISING; DRUG MARKETING; GENETIC SCREENING; HEALTH CARE SYSTEM; HEALTH DISPARITY; HEALTH SURVEY; HUMAN; INFORMATION DISSEMINATION; INTERPERSONAL COMMUNICATION; PRIORITY JOURNAL; REVIEW;

ADVERTISING AS TOPIC; ANTINEOPLASTIC AGENTS; GENETIC TESTING; GOVERNMENT REGULATION; HEALTH LITERACY; HEALTHCARE DISPARITIES; HUMANS; INFORMATION DISSEMINATION; INTERNET; NEOPLASMS; UNITED STATES;

EID: 79251473070     PISSN: 1474175X     EISSN: 14741768     Source Type: Journal    
DOI: 10.1038/nrc2999     Document Type: Review

References (58)

1. Hiatt, R. A. & Rimer, B. K. A new strategy for cancer control research. Cancer Epidemiol. Biomark. Prev. 8, 957-964 (1999).
2. Viswanath, K. The communications revolution and cancer control. Nature Rev. Cancer 5, 828-835 (2005).
3. Viswanath, K. Examining the Health Disparities Research Plan of the National Institutes of Health: Unfinished Business (eds Thomson, G. E., Mitchell, F. & Williams, M. B.) 215-253 (Institute of Medicine, Washington D.C., 2006).
4. National Cancer Institute. HINTS Questions. Health Information National Trends Survey [online], http://hints.cancer.gov/questions/index.jsp (2010).
5. Huh, J., DeLorme, D. E., Reid, L. N. & An, S. Direct-to-Consumer Prescription Drug Advertising: History, Regulation, and Issues.Minnesota Medicine [online], http://www.minnesotamedicine.com/CurrentIssue/ ClinicalJisuMarch2010/tabid/3351/Default.aspx. (2010).
6. Brown, H. Advertising prescription drugs: Sweetening the pill. Br. Med. J. 334, 664 (2007).
7. Cassels, A. Canada may be forced to allow direct to consumer advertising. Br. Med. J. 332, 1469 (2006).
8. Clow, K. Integrated Advertising, Promotion, and Marketing Communications (Prentice Hall, Old Tappan, New Jersey, USA, 2006).
9. Gareau, P. The impact of direct-to-consumer advertising of prescription medicine on consumer's intention to perform external search (University of Guelph, Canada, 2000).
10. Polen, H. H., Khanfar, N. M. & Clauson, K. A. Impact of direct-to-consumer advertising (DTCA) on patient health-related behaviors and issues. Health Mark. Q. 26, 42-55 (2009).
11. Khanfar, N., Loudon, D. & Sircar-Ramsewak, F. FDA direct-to-consumer advertising for prescription drugs: what are consumer preferences and response tendencies- Health Mark. Q. 24, 77-91 (2007).
12. Rubin, P. H. Pharmaceutical advertising as a consumer empowerment device. J. Biolaw Bus. 4, 59-65 (2001).
13. Deshpande, A., Menon, A., Perri, M. & Zinkhan, G. Direct-to-consumer advertising and its utility in health care decision making: A consumer perspective. J. Health Commun. 9, 499-513 (2004).
14. Calfee, J. E. The role of marketing in pharmaceutical research and development. Pharmacoeconomics 20, 77-85 (2002).
15. Williams-Jones, B. 'Be ready against cancer, now': direct-to-consumer advertising for genetic testing. New Genet. Soc. 25, 89-107 (2006).
16. Frosch, D. L., Krueger, P. M., Hornik, R. C., Cronholm, P. F. & Barg, F. K. Creating demand for prescription drugs: A content analysis of television direct-to-consumer advertising. Ann. Fam. Med. 5, 6-13 (2007).
17. Bell, R. A., Kravitz, R. L. & Wilkes, M. S. Direct-to-consumer prescription drug advertising, 1989-1998 -A content analysis of conditions, targets, inducements, and appeals. J. Fam. Pratc. 49, 329-335 (2000).
18. Bell, R. A., Wilkes, M. S. & Kravitz, R. L. The educational value of consumer-targeted prescription drug print advertising. J. Fam. Pract. 49, 1092-1098 (2000).
19. Kaphingst, K. A., Rudd, R. E., Dejong, W. & Daltroy, L. H. Comprehension of information in three direct-to-consumer television prescription drug advertisements among adults with limited literacy. J. Health Commun. 10, 609-619 (2005).
20. Kaphingst, K. A., Rudd, R. E., Dejong, W. & Daltroy, L. H. Literacy demands of product information intended to supplement television direct-to-consumer prescription drug advertisements. Patient Educ. Couns. 55, 293-300 (2004).
21. Huh, J. & Langteau, R. Presumed influence of DTC prescription drug advertising. Commun. Res. 34, 25-52 (2007).
22. Lipsky, M. S. & Taylor, C. A. The opinions and experiences of family physicians regarding direct-to-consumer advertising. J. Fam. Pract. 45, 495-499 (1997).
23. Bell, R. A., Kravitz, R. L. & Wilkes, M. S. Direct-to-consumer prescription drug advertising and the public. J. Gen. Intern. Med. 14, 651-657 (1999).
24. Abel, G. A., Lee, S. J. & Weeks, J. C. Direct-to-consumer advertising in oncology: A content analysis of print media. J. Clin. Oncol. 25, 1267-1271 (2007).
25. Abel, G. A. et al. Direct-to-consumer advertising in oncology. Oncologist 11, 217-226 (2006).
26. Abel, G. A., Burstein, H. J., Hevelone, N. D. & Weeks, J. C. Cancer-related direct-to-consumer advertising: awareness, perceptions, and reported impact among patients undergoing active cancer treatment. J. Clin. Oncol. 27, 4182-4187 (2009).
27. Berg, A. O. et al. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: Recommendation statement. Ann. Intern. Med. 143, 355-361 (2005).
28. Lowery, J. T., Byers, T., Axell, L., Ku, L. S. & Jacobellis, J. The impact of direct-to-consumer marketing of cancer genetic testing on women according to their genetic risk. Genet. Med. 10, 888-894 (2008).
29. Mouchawar, J. et al. Impact of direct-to-consumer advertising for hereditary breast cancer testing on genetic services at a managed care organization: A naturally-occuring experiment. Genet. Med. 7, 191-197 (2005).
30. Mouchawar, J. et al. Assessing controversial direct-to-consumer advertising for hereditary breast cancer testing: Reactions from women and their physicians in a managed care organization. Am. J. Manag. Care 11, 601-608 (2005).
31. Tracy, E. E. Prospects and problems of direct-to-public genetic tests. Per. Med. 5, 511-520 (2008).
32. Gray, S. Direct-to-consumer marketing of genetic tests for cancer: Buyer beware. J. Clin. Oncol. 21, 3191-3193 (2003).
33. Gollust, S. E., Hull, S. C. & Wilfond, B. S. Limitations of direct-to-consumer advertising for clinical genetic testing. J. Am. Med. Assoc. 288, 1762-1767 (2002).
34. Ameer, B. & Krivoy, N. Direct-to-consumer/patient advertising of genetic testing: a position statement of the American College of Clinical Pharmacology. J. Clin. Pharmacol. 49, 886-888 (2009).
35. Mouchawar, J., Ellis, J., Ritzwoller, D., Hensley-Alford, S. & Laurion, S. Impact of direct-to-consumer advertising for hereditary breast cancer testing on genetic services at a managed care organization: A naturally occurring experiment -Reply to letter from Marc Williams. Genet. Med. 7, 514-514 (2005).
36. Goddard, K. A. B. et al. Public awareness and use of direct-to-consumer genetic tests: results from 3 state population-based surveys, 2006. Am. J. Publ. Health 99, 442-445 (2009).
37. Hamilton, J. G., Lobel, M. & Moyer, A. Emotional distress following genetic testing for hereditary breast and ovarian cancer: a meta-analytic review. Health Psychol. 28, 510-518 (2009).
38. Hogarth, S., Javitt, G. & Melzer, D. The current landscape for direct-to-consumer genetic testing: legal, ethincal and policy issues. Annu. Rev. Genomics Hum. Genet. 9, 161-182 (2008).
39. Gupta, S. Do at-home DNA tests work- CNN Living [online] http://tips.blogs.cnn.com/2009/02/27/do-athome-dna-tests-work/(2009).
40. United States Federal Trade Commission. At-home genetic tests: a healthy dose of skepticism may be the best prescription. Facts for consumers [online], http://www.ftc.gov/bcp/edu/pubs/consumer/health/hea02. shtm (2006).
41. Pollack, A. Walgreens delays selling personal genetic test. The New York Times [online], http://www.nytimes.com/2010/05/13/health/13gene.html. (2010).
42. Agency for Healthcare Research and Quality. National Healthcare Disparities Report (Department of Health and Human Services, Rockville, Maryland, USA, 2003).
43. Krieger, N. Defining and investigating social disparities in cancer: critical issues. Cancer Causes Control 16, 5-14 (2005).
44. Lynch, J. W., Smith, G. D., Kaplan, G. A. & House, J. S. Income inequality and mortality: importance to health of individual income, psychosocial environment, or material conditions. Br. Med. J. 320, 1200-1204 (2000).
45. National Cancer Institute. Cancer Health Disparities. (Department of Health and Human Services, Rockville, Maryland, USA 2010).
46. Ramanadhan, S. & Viswanath, K. Health and the information non-seeker: a profile. Health Commun. 20, 131-139 (2006).
47. Finnegan, J. R. & Viswanath, K. Health Behavior and Health Education: Theory, Research, and Practice (eds Glanz, K., Lewis, M. & Rimer, K.) (Jossey-Bass, San Francisco, California, USA, 2002).
48. Chao, B. A. Evaluating the educational content of direct-to-consumer fulfillment materials. Am. J. Health-Syst. Pharm. 62, 620-625 (2005).
49. Manhattan Research. Pharmaceutical Advertisements Leave Consumers Wanting More; While Television Creates Awareness, the Internet Promotes Learning for More Than 13 Million. PRNewswire [online] http://www.prnewswire.com/news- releases/pharmaceuticaladvertisements-leave-consumers-wantingmore-59013162.html/ (2004).
50. Kontos, E. Z., Emmons, K. M., Puleo, E. & Viswanath, K. Communication inequalities and public health implications of adult social networking site use in the US. J. Health Commun. 15, 216-235 (2010).
51. Tu, H. & Cohen, G. Striking jump in consumers seeking health care information. Center for studying health system change [online],http://www. hschange.org/CONTENT/1006/. (2008).
52. Huh, J. & Cude, B. J. Is the information "fair and balanced" in direct-to-consumer prescription drug websites- J. Health Commun. 9, 529-540 (2004).
53. Mayer, R. N., Huh, J. & Cude, B. J. Cues of credibility and price performance of life insurance comparison Web sites. J. Consum. Aff. 39, 71-94 (2005).
54. Ray, T. Myriad launches TV ads to educate women about BRCA risks, sell BRACAnalysis tests. Genomeweb [online], http://www.genomeweb.com/dxpgx/myriad- launches-tv-ads-educate-women-aboutbrca-risks-sell-bracanalysis-tests (2007).
55. Tichenor, P. J., Donohue, G. A. & Olien, C. N. Mass media flow and differential growth in knowledge. Public Opin. Q. 34, 159-170 (1970).
56. Cantor, D. et al. Health Information National Trends Survey (HINTS) 2007: Final Report. (Westat, Rockville, USA, 2009).
57. DiMaggio, P., Hargittai, E., Neuman, W. R. & Robinson, J. P. Social implications of the Internet. Annu. Rev. Sociology 27, 307-336 (2001).
58. Zillien, N. & Hargittai, E. Digital distinction: statusspecific types of internet usage. Soc. Sci. Q. 90, 274-291.